CN111655739A - 一种去除舒更葡糖钠中气相杂质和制备其无定型物的方法 - Google Patents

一种去除舒更葡糖钠中气相杂质和制备其无定型物的方法 Download PDF

Info

Publication number
CN111655739A
CN111655739A CN201980010521.6A CN201980010521A CN111655739A CN 111655739 A CN111655739 A CN 111655739A CN 201980010521 A CN201980010521 A CN 201980010521A CN 111655739 A CN111655739 A CN 111655739A
Authority
CN
China
Prior art keywords
sugammadex sodium
sugammadex
drying
sodium
gas
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201980010521.6A
Other languages
English (en)
Inventor
李发光
高宏
刘群
侯云泽
肖宇
白俊鹏
孟秋月
杨光
祁浩飞
王倩倩
王征
和潇夏
胡佰艳
霍翔宏
王�琦
王利春
王晶翼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sichuan Kelun Pharmaceutical Research Institute Co Ltd
Original Assignee
Tianjin Kelun Pharmaceutical Research Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tianjin Kelun Pharmaceutical Research Co ltd filed Critical Tianjin Kelun Pharmaceutical Research Co ltd
Publication of CN111655739A publication Critical patent/CN111655739A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • A61K31/724Cyclodextrins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

本发明公开了一种去除舒更葡糖钠中气相杂质的方法,包括水溶、蒸馏和干燥等步骤,条件温和,适用于工业放大,制备得到的舒更葡糖钠纯品的气相杂质个数及含量优于原研制剂产品。本发明还进一步公开了一种无定型舒更葡糖钠的制备方法,产物稳定性高,适合制剂生产。

Description

PCT国内申请,说明书已公开。

Claims (16)

  1. PCT国内申请,权利要求书已公开。
CN201980010521.6A 2018-03-28 2019-03-20 一种去除舒更葡糖钠中气相杂质和制备其无定型物的方法 Pending CN111655739A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201810266667 2018-03-28
CN2018102666674 2018-03-28
PCT/CN2019/078808 WO2019184773A1 (zh) 2018-03-28 2019-03-20 一种去除舒更葡糖钠中气相杂质和制备其无定型物的方法

Publications (1)

Publication Number Publication Date
CN111655739A true CN111655739A (zh) 2020-09-11

Family

ID=68059303

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201980010521.6A Pending CN111655739A (zh) 2018-03-28 2019-03-20 一种去除舒更葡糖钠中气相杂质和制备其无定型物的方法

Country Status (2)

Country Link
CN (1) CN111655739A (zh)
WO (1) WO2019184773A1 (zh)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110615860A (zh) * 2018-06-20 2019-12-27 江苏恒瑞医药股份有限公司 一种舒更葡糖钠的纯化方法
CN115708777A (zh) * 2021-08-19 2023-02-24 北京费森尤斯卡比医药有限公司 包含巯基环糊精衍生物或其可药用盐的包装药品和保存方法

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023515087A (ja) 2020-02-28 2023-04-12 メディチェム エセ.ア. スガマデクスを乾燥させるための方法
CN111320712B (zh) * 2020-04-09 2022-03-04 江苏海悦康医药科技有限公司 一种舒更葡糖钠分子内硫醚杂质的合成方法
WO2022055918A1 (en) * 2020-09-09 2022-03-17 Merck Sharp & Dohme Corp. Novel crystalline forms of sugammadex

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101712972B (zh) * 2009-12-18 2012-10-10 江南大学 一种生物法生产α-环糊精的生产工艺
US9879096B2 (en) * 2013-02-14 2018-01-30 Neuland Laboratories Limited Process for preparation of sugammadex sodium
CN107686530B (zh) * 2017-10-16 2019-09-13 河北坤安药业有限公司 一种舒更葡糖钠的合成方法
CN109053933B (zh) * 2018-08-01 2020-10-23 合肥博思科创医药科技有限公司 一种无定型舒更葡糖钠的制备方法

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110615860A (zh) * 2018-06-20 2019-12-27 江苏恒瑞医药股份有限公司 一种舒更葡糖钠的纯化方法
CN115708777A (zh) * 2021-08-19 2023-02-24 北京费森尤斯卡比医药有限公司 包含巯基环糊精衍生物或其可药用盐的包装药品和保存方法

Also Published As

Publication number Publication date
WO2019184773A1 (zh) 2019-10-03

Similar Documents

Publication Publication Date Title
CN111655739A (zh) 一种去除舒更葡糖钠中气相杂质和制备其无定型物的方法
CN109021147B (zh) 一种舒更葡糖钠的纯化方法
JP6692941B2 (ja) スガマデックスの製造及び純化方法
RU2282641C2 (ru) Блок-сополимер с пониженным содержанием примесей, полимерный носитель, фармацевтические препараты в полимерной форме и способы их получения
CN115505051B (zh) 一种精制舒更葡糖钠的方法
CN101959856A (zh) 来那度胺的制备
WO2017203457A1 (en) Solid state forms of empagliflozin
US11168091B2 (en) Quantification and preparation of pharmaceutical grade cantharidin
WO2015104658A2 (en) Amorphous solid dispersion of dapagliflozin and process for the preparation of amorphous dapagliflozin
CN113735928A (zh) 一种n4-羟基胞苷衍生物及其制备方法和用途
US10526422B2 (en) Process for preparation and purification of Sugammades sodium
EP2956439B1 (en) Process for preparing atazanavir sulphate
WO2012145888A1 (zh) 一种罗库溴铵的纯化方法
HRP20020231A2 (en) ISOSTRUCTURAL PSEUDOPOLYMORPHS OF 9-DEOXO-9a-AZA-9a-METHYL-9a-HOMOERYTHROMYCIN A
CN118556041A (zh) 用于纯化5-氨基水杨酸的工艺
CN102391326B (zh) 一种盐酸克林霉素棕榈酸酯化合物及其制法
CA3189271A1 (en) A precipitation process for amorphous letermovir
CN114349769A (zh) 一种头孢卡品酯e型异构体的制备方法
KR20110111494A (ko) 티게사이클린의 단리방법
JPH11158136A (ja) 残留溶媒量の少ない結晶質イオヘキソールの製造方法
CN102617327A (zh) 右旋布洛芬化合物及其制法
CN115348974B (zh) 用于干燥舒更葡糖的方法
US6767998B2 (en) Method for preparing purified erythromycin
EP4346774A1 (en) Process to reduce ivermectin particle size
CN118084930A (zh) 苯酞异喹啉类生物碱及其药学上可接受的盐及其应用、药物组合物及其应用

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
TA01 Transfer of patent application right

Effective date of registration: 20220119

Address after: NO.666, Section 2, Xinhua Avenue, cross strait science and Technology Industry Development Park, Wenjiang District, Chengdu City, Sichuan Province

Applicant after: SICHUAN KELUN PHARMACEUTICAL RESEARCH INSTITUTE Co.,Ltd.

Address before: 300457 n1505, 15 / F, experimental building of Tianjin International Biomedical Joint Research Institute, No. 220 Dongting Road, Tianjin Economic and Technological Development Zone, Tianjin

Applicant before: TIANJIN KELUN PHARMACEUTICAL RESEARCH Co.,Ltd.

TA01 Transfer of patent application right